Abemaciclib Inhibits Renal Tubular Secretion Without Changing Glomerular Filtration Rate
Author:
Affiliation:
1. Eli Lilly and Company Indianapolis Indiana USA
2. Covance Early Clinical Development Madison Wisconsin USA
3. Brigham and Women's Hospital Boston Massachusetts USA
Funder
Eli Lilly and Company
National Institutes of Health
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1296
Reference38 articles.
1. Efficacy and Safety of Abemaciclib, an Inhibitor of CDK4 and CDK6, for Patients with Breast Cancer, Non–Small Cell Lung Cancer, and Other Solid Tumors
2. MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
3. Serum creatinine as an index of renal function: new insights into old concepts;Perrone R.D.;Clin. Chem.,1992
4. Serum Creatinine and Renal Function
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases;International Journal of Clinical Pharmacy;2024-01-19
2. Case report: abemaciclib-induced syndrome of inappropriate antidiuretic hormone (SIADH) without underlying kidney injury in a patient with early-stage estrogen receptor (ER)+ breast cancer;Frontiers in Medicine;2024-01-16
3. CDK4/6 inhibitors in the treatment of metastatic breast cancer: Focus on toxicity and safety;Seminars in Oncology;2024-01
4. Unraveling Pseudo Kidney Injury: The Significance of Understanding Our “MATE” in Molecular-Targeted Therapies;Journal of Thoracic Oncology;2024-01
5. Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function;Journal of Thoracic Oncology;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3